Online Delivery of Psychotherapy, Tailored to Patients' Suffering From Mental Health Problems Due to COVID-19
Mental Health Issue, Covid19, Anxiety Disorders
About this trial
This is an interventional treatment trial for Mental Health Issue focused on measuring Anxiety, Depression, COVID-19, Online Psychotherapy, Mental Health
Eligibility Criteria
Inclusion Criteria:
- Capacity to consent
- Diagnosis of MDD and/or GAD
- Ability to speak and read English
- Consistent and reliable access to the internet
Exclusion Criteria:
- Active psychosis
- Acute mania
- Severe alcohol or substance use disorder
- Active suicidal or homicidal ideation
- Participant receiving another form of psychotherapy
Sites / Locations
- Hotel Dieu Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
e-Psychotherapy
Treatment as Usual
Participants will receive a 9-week program with CBT, mindfulness, and problem-based therapy, in addition to TAU. The content will be customized to reflect challenges faced through the COVID-19 pandemic and developed into interactive and engaging modules. All sessions and interactions will occur through Online Psychotherapy Tool (OPTT), a secure online platform. Participants will be assigned to a team of psychiatrists and social workers (SWs). The SW working with each patient will assign a pre-designed therapy module to that patient on a specific day of the week through OPTT. Participants will then be able to access the therapy content at any time throughout the week. Each module will highlight a different topic and include general information, an overview of skills, and homework that is to be completed by a specific day that week. This homework will be directly submitted through OPTT to the clinician who will provide personalized feedback to the patient.
The control group will receive treatment as usual during the first 9 weeks; if they still present significant symptoms (less than 50% response to treatment from baseline), they will be offered the e-psychotherapy program.